Insurance services company CNO Financial Group (NYSE: CNO) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 8.5% year on year to $1.03 billion. Its non-GAAP profit of $1.29 per share was 38.7% above analysts’ consensus estimates.

Is now the time to buy CNO? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

CNO Financial Group posted better-than-expected results in Q1, with revenue growth and a significant beat on non-GAAP earnings per share. Management attributed much of the quarter’s performance to robust sales across both its Consumer and Worksite divisions, with total new annualized premiums rising. CEO Gary Bhojwani highlighted the company’s middle-market focus and captive agent distribution model as key differentiators supporting ongoing sales momentum. Additionally, improvements in insurance product margin and investment yields contributed to profitability, while technology-driven productivity gains and agent count growth further underscored the quarter’s operational execution.

Looking ahead, management is prioritizing continued growth in operating earnings and improvements in return on equity by leveraging product diversity, disciplined expense management, and reinvestment in technology. CFO Paul McDonough noted that rate increases in the Medicare Supplement business are expected to support future benefit ratios, while ongoing investments in digital and artificial intelligence are designed to enhance agent productivity and the customer experience. Management remains focused on stable, long-term returns and aims to further increase its ROE target, with McDonough stating, “Our aim is to continue to improve upon that [12% ROE].”

Key Insights from Management’s Remarks

CNO’s management pointed to strong sales performance, product diversification, and operational efficiency as major drivers of the quarter’s outperformance versus analyst expectations.

• Medicare Supplement shift: CNO saw a notable increase in Medicare Supplement sales, responding to industrywide disruption in Medicare Advantage. Management highlighted a 53% rise in Medicare Supplement new annualized premiums, driven by consumers switching coverage amid widespread plan changes and terminations.

• Technology-driven sales productivity: The company’s investments in digital tools and artificial intelligence, such as AI-assisted call routing in the Colonial Penn call center, have led to shorter wait times and improved sales conversion rates. These initiatives are part of a broader strategy to boost agent productivity and diversify marketing channels beyond traditional television.

• Worksite segment momentum: The Worksite division reported its sixteenth consecutive quarter of sales growth, with life insurance up 56% and hospital indemnity insurance up 121%. Geographic expansion and deeper penetration into small and mid-sized businesses contributed significantly to new client acquisition and higher agent recruiting.

• Investment income and portfolio discipline: CNO achieved its tenth consecutive quarter of growth in net investment income, supported by higher book yields and disciplined asset allocation. The company remains focused on maintaining a high-quality, liquid investment portfolio despite ongoing volatility in credit markets.

• Expense and capital management: Lower-than-expected expenses in the quarter supported margins, though management expects costs to normalize over the year. Capital return to shareholders continued through dividends and share repurchases, with a 7% reduction in diluted shares outstanding reported for the quarter.

Drivers of Future Performance

CNO’s outlook is guided by ongoing product diversification, anticipated benefits from rate actions, and disciplined capital management amid macroeconomic uncertainty.

• Medicare Supplement rate increases: Upcoming rate increases for Medicare Supplement policies are expected to offset higher claims and improve benefit ratios by year-end. Management emphasized that the portfolio’s diversity allows the company to navigate fluctuations in specific product lines while maintaining stable total margins.

• Technology and agent productivity: Continued investments in data, digital platforms, and artificial intelligence are aimed at driving further efficiency gains. Management believes these efforts will enhance both customer experience and agent effectiveness, supporting long-term growth in both the Consumer and Worksite segments.

• Capital deployment flexibility: CNO is maintaining a robust capital and liquidity position, giving it the flexibility to reinvest in the business or return capital to shareholders as opportunities arise. However, management cautioned that macroeconomic volatility, particularly in the credit and funding agreement-backed note (FABN) markets, could create short-term uncertainties around investment income and capital allocation.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will monitor (1) the impact of Medicare Supplement rate increases on benefit ratios and margin improvement, (2) the effectiveness of ongoing technology and AI investments in driving agent productivity and sales growth, and (3) the company’s ability to maintain disciplined capital deployment while navigating potential volatility in investment markets. Execution in these areas will be critical for sustaining CNO’s growth trajectory.

CNO Financial Group currently trades at $44.19, in line with $44.45 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.